Skip to search.
 All Ordinaries Up 1.49%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
2.18 Down 0.02(0.91%) 06:00
Add to Portfolio
Prev Close:2.20
Open:2.19
Bid:2.15 x 5000
Ask:2.63 x 900
1y Target Est:8.80
Beta:2.9
Earnings Date:4 Aug - 10 Aug (Est.)
Day's Range:2.13 - 2.22
52wk Range:1.85 - 4.97
Volume:1,351,022
Avg Vol (3m):1,535,330
Market Cap:293.04M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTADown 0.91%293.04M
INFIUp 3.00%521.81M
NVSUp 1.30%241.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.74
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback